From January 1, 2022 to March 31, 2022, the company has repurchased 653,900 shares, representing 1.45% for ¥1,282.85 million. With this, the company has completed the repurchase of 719,400 shares, representing 1.6% for ¥1,411.44 million under the buyback announced on November 4, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,950 JPY | -0.46% | -3.70% | -3.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.32% | 552M | |
+18.71% | 44.35B | |
+19.44% | 15.08B | |
+19.49% | 14.37B | |
+57.58% | 13.06B | |
-0.05% | 6.79B | |
-9.70% | 6.75B | |
-8.87% | 5.73B | |
+12.55% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2021.